4.7 Article

The significance of N6-methyladenosine-modified non-coding RNAs in different disorders

Related references

Note: Only part of the references are listed.
Article Oncology

N6-methyladenosine upregulates miR-181d-5p in exosomes derived from cancer-associated fibroblasts to inhibit 5-FU sensitivity by targeting NCALD in colorectal cancer

Shengli Pan et al.

Summary: This study found that exosomal miR-181d-5p inhibits the sensitivity of colorectal cancer cells to 5-FU by targeting NCALD. This suggests that exosomal miR-181d-5p may serve as a potential prognostic marker for CRC.

INTERNATIONAL JOURNAL OF ONCOLOGY (2022)

Article Oncology

A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p

Yuhang Hu et al.

Summary: This study reveals a negative feedback regulation between the m6A reader YTHDF3 and the glycolytic lncRNA DICER1-AS1, which is involved in glycolysis and tumorigenesis of pancreatic cancer.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

METTL14-mediated m6A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p/AKT1S1 axis

Hui-Ning Fan et al.

Summary: Our study reveals that METTL14-mediated m(6)A modification of circORC5 suppresses the progression of gastric cancer by regulating the miR-30c-2-3p/AKT1S1 axis.

MOLECULAR CANCER (2022)

Article Oncology

Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis

Quan Ling et al.

Summary: This study investigates the detailed molecular mechanisms by which propofol enhances DDP-sensitivity in NSCLC cells. It identifies a novel m6A-dependent miR-486-5p/RAP1-NF-kappa B axis that is closely associated with this process.

BMC CANCER (2022)

Article Neurosciences

Identification and characterization of N6-methyladenosine circular RNAs in the spinal cord of morphine-tolerant rats

Manyu Xing et al.

Summary: In this study, the patterns of m(6)A-methylation of circRNAs in the spinal cord of morphine-tolerant rats were explored. The results indicated that m(6)A modification of circRNAs may be involved in the pathogenesis of morphine tolerance, providing new insights into the epigenetic etiology and pathology of this condition.

FRONTIERS IN NEUROSCIENCE (2022)

Review Genetics & Heredity

Emerging Roles and Potential Applications of Non-Coding RNAs in Cervical Cancer

Deepak Parashar et al.

Summary: Cervical cancer is a common cancer in women worldwide. It can be prevented through vaccination, screening, and treatment. However, prognosis for advanced or metastatic cervical cancer is poor and current treatment options are limited. Understanding the mechanisms of metastasis and finding new therapeutic targets are crucial. Non-coding RNAs play important roles in transcriptional processes and are considered key regulators of biological processes. Recent studies have revealed the significant roles of ncRNAs in the progression, metastasis, treatment, and diagnosis of cervical cancer.

GENES (2022)

Article Biotechnology & Applied Microbiology

N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer

Zhijia Jiang et al.

Summary: This study revealed the role of miR-380-3p in regulating pancreatic cancer progression through m6A modification and PTEN/Akt pathway. Overexpression of miR-380-3p promoted cell proliferation, epithelial-mesenchymal transition, and tumorigenesis, while knockdown of miR-380-3p had the opposite effects. Furthermore, miR-380-3p targeted PTEN to activate the downstream Akt signal pathway. This study provides important insights into the treatment and diagnosis of pancreatic cancer.

BIOENGINEERED (2022)

Article Biology

circRERE regulates the expression of GBX2 through miR-1299 and ZC3H13/N6-methyladenosine (m6A) to promote growth and invasion of hepatocellular carcinoma cells

Yong-hua Lin et al.

Summary: This study found that circRERE promotes the growth and invasion of hepatocellular carcinoma (HCC) cells by regulating the expression of GBX2 through miR-1299 and ZC3H13/m(6)A.

JOURNAL OF BIOSCIENCES (2022)

Article Cell Biology

MiR-103-3p targets the m6A methyltransferase METTL14 to inhibit osteoblastic bone formation

Zhongyang Sun et al.

Summary: The study identified the miR-103-3p/METTL14/m(6)A signaling axis as a critical regulator of osteoblast activity, with miR-103-3p targeting Mettl14 to inhibit osteoblast function and METTL14 promoting osteoblast activity through m(6)A methylation of miR-103-3p. Therapeutic inhibition of miR-103-3p reversed the decreased bone formation, indicating the potential of this signaling axis as a target for ameliorating osteoporosis.

AGING CELL (2021)

Article Biochemistry & Molecular Biology

m6A-seq analysis of microRNAs reveals that the N6-methyladenosine modification of miR-21-5p affects its target expression

Hanming Wang et al.

Summary: The study reveals the presence of m(6)A modification in mature miRNAs and its potential impact on cancer-related mRNA responses. Depletion of ALKBH5 alters the m(6)A abundance of miR-21-5p and subsequently affects its target gene expression levels. The m(6)A modification directly affects the silencing potency of miR-21-5p towards target genes in NSCLC cells.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)

Article Biochemistry & Molecular Biology

N6-methyladenosine modification of circular RNA circ-ARL3 facilitates Hepatitis B virus-associated hepatocellular carcinoma via sponging miR-1305

Xi Rao et al.

Summary: The study identified a HBV-related circRNA, circ-ARL3, and demonstrated that silencing this circRNA inhibited the proliferation and invasion of HBV+ HCC cells, and was correlated with malignant clinical features and poor prognosis. Mechanistically, HBx protein upregulated METTL3 expression to increase m(6)A modification of circ-ARL3, promoting HBV+ HCC progression.

IUBMB LIFE (2021)

Article Biochemistry & Molecular Biology

m(6)A-mediated upregulation of AC008 promotes osteoarthritis progression through the miR-328-3p-AQP1/ANKH axis

Jiashu Yang et al.

Summary: The study reveals the critical role of AC008 in the pathogenesis of OA through the miR-328-3p-AQP1/ANKH pathway, suggesting AC008 as a potential therapeutic target for OA.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Article Medicine, Research & Experimental

N-methyladenosine reader YTHDF2-mediated long noncoding RNA FENDRR degradation promotes cell proliferation in endometrioid endometrial carcinoma

Jie Shen et al.

Summary: Dysregulation of long noncoding RNA (LncRNA) FENDDR is closely related to cancer progression. This study reveals that the decreased expression and elevated m6A methylation levels of LncRNA FENDRR are associated with endometrioid endometrial carcinoma (EEC). YTHDF2-mediated degradation of LncRNA FENDRR promotes cell proliferation in EEC by increasing SOX4 expression.

LABORATORY INVESTIGATION (2021)

Article Biotechnology & Applied Microbiology

N6-methyladenosine (m6A)-mediated lncRNA DLGAP1-AS1enhances breast canceradriamycin resistance through miR-299-3p/WTAP feedback loop

Tao Huang et al.

Summary: DLGAP1-AS1 is upregulated in ADR-resistant breast cancer cells, promoting drug resistance and proliferation, leading to poorer clinical prognosis. Additionally, DLGAP1-AS1 is involved in chemotherapy resistance through the miR-299-3p/WTAP pathway in breast cancer.

BIOENGINEERED (2021)

Article Medical Laboratory Technology

A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer

Jie Wu et al.

Summary: This study identified ten independent m6A-related LncRNAs in TNBC and established a prognostic score risk model. Results showed that the PS model had good prognostic abilities in predicting overall survival of TNBC patients. These LncRNAs may serve as potential biomarkers for predicting the prognostic risk of TNBC.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)

Article Oncology

Downregulation of microRNA-6125 promotes colorectal cancer growth through YTHDF2-dependent recognition of N6-methyladenosine-modified GSK3β

Hongyan Li et al.

Summary: MiR-6125 is downregulated in CRC, negatively correlated with tumor size and prognosis. MiR-6125 targets YTHDF2, downregulates its protein, stabilizes m6A-modified GSK3 beta mRNA. Increased GSK3 beta protein inhibits Wnt/beta-catenin/Cyclin D1 pathway proteins, leading to G0-G1 phase arrest and inhibiting CRC cell proliferation.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Review Endocrinology & Metabolism

Epigenetic regulation of N6-methyladenosine modifications in obesity

Mingli Sun et al.

Summary: Obesity is closely related to metabolic diseases, and m6A modification has been shown to potentially play a regulatory role in obesity-related biological processes.

JOURNAL OF DIABETES INVESTIGATION (2021)

Review Medicine, Research & Experimental

MicroRNA: A signature for cancer progression

Bashdar Mahmud Hussen et al.

Summary: MicroRNAs (miRNAs) are small non-coding RNAs that play a critical role in cancer by post-transcriptionally controlling gene expression. They are involved in the initiation, progression, and metastasis of cancer, and can be used to classify genes affecting cancer pathways.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Cell Biology

METTL3/N6-methyladenosine/ miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-κB pathway activation

Erpeng Liu et al.

Summary: Our research demonstrates that miR-21-5p and m(6)A modification are significantly increased in obstructive renal fibrosis, with miR-21-5p playing a crucial role in enhancing inflammation through activation of the SPRY1/ERK/NF-kB pathway. Additionally, METTL3 promotes obstructive renal fibrosis by driving maturation of miR-21-5p, thus providing a deeper understanding of the mechanism underlying renal fibrosis.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Biochemistry & Molecular Biology

N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer

Zhenchuan Liu et al.

Summary: In this study, it was found that circIGF2BP3 contributes to immune escape in NSCLC by upregulating PKP3 expression and stabilizing OTUB1 mRNA to increase PD-L1 abundance. The impact on the CD8(+) T cell response was observed, shedding light on a novel mechanism of PD-L1 regulation in NSCLC and providing insight on enhancing the efficacy of anti-PD-1 treatment.

MOLECULAR CANCER (2021)

Article Biochemistry & Molecular Biology

Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis

Yaxin Guo et al.

Summary: The study shows that circ3823 promotes CRC growth, metastasis, and angiogenesis through the circ3823/miR-30c-5p/TCF7 axis, suggesting its potential as a new diagnostic marker or treatment target for CRC patients. Additionally, the study also reveals the involvement of m6A modification in regulating the degradation of circ3823.

MOLECULAR CANCER (2021)

Article Biochemistry & Molecular Biology

N6-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression

Pengxiang Chen et al.

Summary: The study revealed the critical role of ALKBH5 in miRNA biogenesis and offered new insights for developing treatment strategies in esophageal cancer.

ONCOGENE (2021)

Article Biotechnology & Applied Microbiology

m6A-Induced LncRNA MEG3 Suppresses the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cell Through miR-544b/BTG2 Signaling

Jian Wu et al.

Summary: In HCC, MEG3 and BTG2 are downregulated while miR-544b is upregulated. MEG3 regulates BTG2 expression through miR-544b, affecting the malignant behavior of HCC. METTL3 influences the m6A modification of MEG3 and its expression level, providing potential new targets for HCC research.

ONCOTARGETS AND THERAPY (2021)

Article Oncology

m(6)A Modification of lncRNA NEAT1 Regulates Chronic Myelocytic Leukemia Progression via miR-766-5p/CDKN1A Axis

Fang-Yi Yao et al.

Summary: This study reveals a novel METTL3/NEAT1/miR-766-5p/CDKN1A axis that plays a critical role in the progression of CML. NEAT1 expression is decreased in CML cell lines and PBMCs of CML patients, with METTL3-mediated m6A modification influencing its aberrant expression. MiR-766-5p, upregulated in CML PBMCs, interferes with the effects of NEAT1 on CML cell viability and apoptosis.

FRONTIERS IN ONCOLOGY (2021)

Article Medicine, Research & Experimental

m6A Methylation of Precursor-miR-320/RUNX2 Controls Osteogenic Potential of Bone Marrow-Derived Mesenchymal Stem Cells

Gege Yan et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Article Biochemistry & Molecular Biology

ASIC1a regulates miR-350/SPRY2 by N6-methyladenosine to promote liver fibrosis

Yueqin Zhu et al.

FASEB JOURNAL (2020)

Article Medicine, Research & Experimental

METTL3 Induces AAA Development and Progression by Modulating N6-Methyladenosine-Dependent Primary miR34a Processing

Lintao Zhong et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Article Biochemistry & Molecular Biology

N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19

Yamin Su et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2020)

Article Biochemistry & Molecular Biology

Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine

Simeng Wen et al.

MOLECULAR CANCER (2020)

Article Medicine, Research & Experimental

N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic Tool

Josephine Briand et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Article Biochemistry & Molecular Biology

RNAmod: an integrated system for the annotation of mRNA modifications

Qi Liu et al.

NUCLEIC ACIDS RESEARCH (2019)

Review Biochemistry & Molecular Biology

Functions of N6-methyladenosine and its role in cancer

Liuer He et al.

MOLECULAR CANCER (2019)

Article Biochemistry & Molecular Biology

N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1

Hongsheng Wang et al.

MOLECULAR CANCER (2019)

Article Biochemistry & Molecular Biology

N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential

Dandan Yang et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Multidisciplinary Sciences

Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq

Dan Dominissini et al.

NATURE (2012)